Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.
Lo
C M
CM
Department of Surgery, University of Hong Kong, Queen Mary Hospital, China.
Fan
S T
ST
Liu
C L
CL
Chan
K L
KL
Ng
I O
IO
Lai
C L
CL
Lau
G K
GK
Fung
S K
SK
Wong
J
J
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006723:Hong Kong; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus